Private Trust Company’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Private Trust Company’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-20	Closed	-$2.31K	–	2473
2023 Q3	$2.31K	Buy	+20	New	+$2.15K	﹤0.01%	2091
2023 Q2	–	Sell	-103	Closed	-$11.2K	–	2398
2023 Q1	$11.2K	Sell	103 -38	-27%	-$4.2K	﹤0.01%	1533
2022 Q4	$16K	Sell	141 -51	-27%	-$4.24K	﹤0.01%	1394
2022 Q3	$12K	Buy	192 +42	+28%	+$2.94K	﹤0.01%	1400
2022 Q2	$12K	Buy	+150	New	+$14.2K	﹤0.01%	1438
2014 Q4	–	Sell	-46	Closed	-$1K	–	1423
2014 Q3	$1K	Hold	46	–	–	﹤0.01%	1839
2014 Q2	$1K	Buy	+46	New	+$657	﹤0.01%	1855

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Private Trust Company's HZNP Position: Q4 2023 in Review

Private Trust Company sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 20 shares — an estimated $2.31K sold.

Private Trust Company first reported a position in HZNP in Q2 2014 and held it in 7 quarters. The position peaked at $16K in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Private Trust Company reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Private Trust Company sold 20 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.31K.
Private Trust Company first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2014 and held it in 7 quarters.
Private Trust Company's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $16K in Q4 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Private Trust Company's 13F filing for Q4 2023, filed 24 Jan 2024.